Fluticasone Inhaled
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An inhaled corticosteroid (ICS) that is a cornerstone of persistent asthma management. Fluticasone propionate (Flovent) and fluticasone furoate (Arnuity) deliver potent topical anti-inflammatory effects directly to the airways with minimal systemic absorption. Classified as the preferred controller therapy for mild-to-severe persistent asthma in all age groups. Reduces airway inflammation, hyperresponsiveness, exacerbation frequency, and improves lung function.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An inhaled corticosteroid (ICS) that is a cornerstone of persistent asthma management. NutriStack rates the supporting evidence as strong. Common adult dosing is Flovent HFA: 88-440 mcg BID (adults); Arnuity Ellipta: 100-200 mcg once daily; dose titrated to lowest effective dose for asthma control (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete calcium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: first-line controller for persistent asthma (all severity levels), reduces asthma exacerbations and er visits, improves lung function (fev1) and symptom control. 10 sources indexed (2004–2022), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to intracellular glucocorticoid receptors in airway epithelial cells, inflammatory cells, and structural cells. The activated receptor-steroid complex translocates to the nucleus and modulates gene transcription: upregulating anti-inflammatory proteins (lipocortin-1, IL-10, IkB-alpha) and suppressing pro-inflammatory mediators (cytokines IL-1/IL-6/IL-8/TNF-alpha, chemokines, adhesion molecules, and enzymes like COX-2 and iNOS). This reduces eosinophilic inflammation, mast cell degranulation, mucus hypersecretion, and airway remodeling over weeks of consistent use.
Dosing & protocol.
Delivered directly to the lungs via inhalation. Oral bioavailability is <1% (extensive first-pass metabolism). Systemic absorption primarily from lung deposition. Rinse mouth after use to prevent oral candidiasis and dysphonia.5,8
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
MildLong-term or high-dose inhaled corticosteroid exposure can reduce bone formation and contribute to poorer calcium balance.
Full safety detail.
Side effects
- Oral candidiasis (thrush), preventable by rinsing mouth after use
- Dysphonia (hoarseness)
- Pharyngitis and cough
- Headache
- Adrenal suppression (with high doses or prolonged use)
- Reduced bone mineral density (with chronic high-dose use)
- Growth suppression in children (small, generally clinically insignificant)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysisPMIDManeechotesuwan K, Singh D, Fritscher LG et al. · Respiratory medicine · 2022
Maneechotesuwan K, Singh D, Fritscher LG et al.. Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis. Respiratory medicine. 2022
- 2Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic reviewPMIDMuley P, Shah M, Muley A · Current drug safety · 2013
Muley P, Shah M, Muley A. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review. Current drug safety. 2013
- 3Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysisPMIDMasoli M, Weatherall M, Holt S et al. · The European respiratory journal · 2006
Masoli M, Weatherall M, Holt S et al.. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. The European respiratory journal. 2006
- 4Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic reviewPMIDDyer MJ, Halpin DM, Stein K · BMC family practice · 2006
Dyer MJ, Halpin DM, Stein K. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC family practice. 2006
- 5Systematic review of the dose-response relation of inhaled fluticasone propionatePMIDMasoli M, Weatherall M, Holt S et al. · Archives of disease in childhood · 2004
Masoli M, Weatherall M, Holt S et al.. Systematic review of the dose-response relation of inhaled fluticasone propionate. Archives of disease in childhood. 2004
Reference material
5- 6GINA (Global Initiative for Asthma). Global Strategy for Asthma Management and Prevention. 2023.Source linkedPMID
- 7Adams NP et al. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev. 2008.Source linkedPMID
- 8Suissa S et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000.Source linkedPMID
- 9Tagaya E, Shinada J, Nagase H et al.. The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) study. The Journal of asthma : official journal of the Association for the Care of Asthma. 2025Source linkedPMID
- 10Ismaila AS, Haeussler K, Czira A et al.. Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in therapy. 2022Source linkedPMID
Common questions.
Quick answers about Fluticasone Inhaled, drawn from the data on this page.
What is Fluticasone Inhaled?
An inhaled corticosteroid (ICS) that is a cornerstone of persistent asthma management. Fluticasone propionate (Flovent) and fluticasone furoate (Arnuity) deliver potent topical anti-inflammatory effects directly to the airways with minimal systemic absorption. Classified as the preferred controller therapy for mild-to-severe persistent asthma in all age groups. Reduces airway inflammation, hyperresponsiveness, exacerbation frequency, and improves lung function.
What is Fluticasone Inhaled used for?
Commonly cited benefits of Fluticasone Inhaled include: First-line controller for persistent asthma (all severity levels); Reduces asthma exacerbations and ER visits; Improves lung function (FEV1) and symptom control; Reduces airway hyperresponsiveness; Low systemic absorption minimizes steroid side effects. NutriStack rates the overall evidence as strong.
What is a typical dose of Fluticasone Inhaled?
A typical adult dose of Fluticasone Inhaled is Flovent HFA: 88-440 mcg BID (adults); Arnuity Ellipta: 100-200 mcg once daily; dose titrated to lowest effective dose for asthma control (as prescribed by your physician). The commonly recommended form is Metered-dose inhaler (MDI) or dry powder inhaler (DPI). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Fluticasone Inhaled?
Reported side effects include oral candidiasis (thrush), preventable by rinsing mouth after use, dysphonia (hoarseness), pharyngitis and cough, headache, adrenal suppression (with high doses or prolonged use), reduced bone mineral density (with chronic high-dose use). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Fluticasone Inhaled?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Fluticasone Inhaled in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.